IXICO plc (AIM: IXI)
Health Care · Life Sciences Tools & Services · GB
£0.08
+3.33% today · -35.4% 1Y
IXICO plc (AIM: IXI) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $22.46M.
Over the last twelve months the share price has lost 35.4%, trading between 0.06 and 0.14.
Tweenvest scores IXICO plc across four factors: quality 59/100, value 54/100, growth 2/100. Its strongest factor is quality.
IXI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.46M
- Revenue (TTM)
- $9.61M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- £0.14
- 52-week low
- £0.06
- Avg volume (3M)
- —
- Shares outstanding
- 218.97M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| genedrive plcAIM: GDR | $24.43M | £0.01 | -2.13% |
| Telescope Innovations Corp.CNSX: TELI | $23.51M | CA$0.42 | +1.22% |
| DT&CRO CO., Ltd.KOSDAQ: A383930 | $23.44M | ₩2,465.00 | +24.94% |
| BioLASCO Taiwan Co., Ltd.TPEX: 6662 | $22.96M | NT$28.50 | -0.35% |
| HyEnergy S.A.WSE: HEN | $21.40M | zł— | — |
| Brooks Laboratories LimitedNSEI: BROOKS | $21.35M | Rs70.13 | +27.97% |
| Human Metabolome Technologies, Inc.TSE: 6090 | $21.22M | ¥604.00 | -0.33% |
| atect corporationTSE: 4241 | $20.21M | ¥724.00 | +1.54% |
Figures last refreshed Oct 11, 2026.